Manzoor, 2012, J. Natl Cancer Inst, 10.1158/0008-5472.CAN-12-1683
Dvorak, 1988, Am J Pathol, 133, 95
Maeda, 2001, Adv. Enzyme Regul., 41, 189, 10.1016/S0065-2571(00)00013-3
Maeda, 1989, Crit. Rev. Ther. Drug Carrier Sys., 6, 193
Yuan, 1994, Cancer Res, 54, 3352
Wu NZ, 1993, Cancer Res, 53, 3765
Gaber, 1996, Int. J. Radiat. Oncol., Biol., Phys., 36, 1177, 10.1016/S0360-3016(96)00389-6
Kong, 2000, Cancer Res, 60, 4440
Kong, 2001, Cancer Res, 61, 3027
Chen, 2008, Int. J. Hyperthermia, 24, 475, 10.1080/02656730701854767
Bangham, 1965, J. Mol. Biol., 13, 238, 10.1016/S0022-2836(65)80093-6
Allen, 2004, Science, 303, 1818, 10.1126/science.1095833
Landon, 2011, The Open Nanomedicine Journal, 3, 38, 10.2174/1875933501103010038
Needham, 2000, Cancer Research, 60, 1197
D. Needham and AnaPonce, Nanoscale Drug Delivery Vehicles for Solid Tumors: A New Paradigm for Localized Drug Delivery Using Temperature Sensitive Liposomes, in Nanotechnology for Cancer Therapy, ed. M.M. Amiji, CRC Press, Boca Raton, FL, 2006, pp. 677–719
ClinicalTrials.gov. Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall (DIGNITY), 2010, available from: http://www.clinicaltrials.gov/ct2/show/NCT00826085?term=thermodox+rcw&rank=1
ClinicalTrials.gov. A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver, 2010, available from: http://www.clinicaltrials.gov/ct2/show/NCT00441376?term=thermodox+RFA+liver&rank=1
ClinicalTrials.gov. Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC), 2010, available from: http://www.clinicaltrials.gov/ct2/show/NCT00617981?term=NCT00617981&rank=1
Yatvin, 1978, Design of liposomes for enhanced local release of drugs by hyperthermia., 202, 1290
D. Marsh , Handbook of Lipid Bilayers, CRC Press, Boca Raton, 1990
Mills, 2005, Biochim. Biophys. Acta, Biomembr., 1716, 77, 10.1016/j.bbamem.2005.08.007
Yatvin, 1981, Cancer Res, 41, 1602
Kong, 1999, Int. J. Hyperthermia, 15, 345, 10.1080/026567399285558
Celsion, 2010 [accessed August 8, 2010]. Available from: http://www.celsion.com
Anyarambhatla, 1999, J. Liposome Res., 9, 491, 10.3109/08982109909035549
Kong, 2000, Cancer Res, 60, 6950
Mills, 2004, Methods Enzymol., 387, 82, 10.1016/S0076-6879(04)87006-X
Needham, 2000, Cancer Res, 60, 1197
Needham, 2001, Adv. Drug Delivery Rev., 53, 285, 10.1016/S0169-409X(01)00233-2
D. Needham , Temperature-sensitive liposome formulation, Pat. WO99/65466, 23rd December, 1999
Mills, 2005, Biochim. Biophys. Acta, Biomembr., 1716, 77, 10.1016/j.bbamem.2005.08.007
Papahadjopoulos, 1973, Biochim. Biophys. Acta, Biomembr., 311, 330, 10.1016/0005-2736(73)90314-3
Anyarambhatla, 1999, J. Liposome Res., 9, 491, 10.3109/08982109909035549
Mills, 2004, Methods Enzymol., 387, 82, 10.1016/S0076-6879(04)87006-X
A. Wright , Drug loading and release from a thermally sensitive liposome, in Mechanical Engineering and Materials Science, Duke University, Durham, 2006
Park, 2012, Journal of Liposome Research
Poon, 2009, Expert Opin. Pharmacother., 10, 333, 10.1517/14656560802677874
Pappenheimer, 1951, Am J Physiol, 167, 13, 10.1152/ajplegacy.1951.167.1.13
Vujaskovic, 2010, Int. J. Hyperthermia, 26, 514, 10.3109/02656731003639364
Celsion Corporation and PhilipsHealthcare, Investigational New Drug/Investigational Device Exemption (IND/IDE) application for a phase 2 study of ThermoDox and MR-HIFU in bone cancer, U. S. FDA, 2012
A. M. Wright , Drug loading and release from a thermally sensitive liposome, in Mechanical Engineering and Materials Science, Duke University, Durham, 2006, pp. 1–322
R. C. New , R.Liposomes, A practical approach. Practical Approach Series, ed. D.R.A.B.D. Hames, IRL Press, Oxford New York Tokyo, 1990, pp. 1–31
Mayer, 1986, Biochim. Biophys. Acta, Biomembr., 857, 123, 10.1016/0005-2736(86)90105-7
D. Needham , Session 05: Amphiphilic membranes and templates. Lipid membranes: Biological inspiration for micro and nano encapsulation technologies, especially drug delivery, in Materials Research Society, Materials Research Society, San Francisco, 2003
Mills, 2004, Methods Enzymol, 387, 82, 10.1016/S0076-6879(04)87006-X
Hope, 1985, Biochim. Biophys. Acta, Biomembr., 812, 55, 10.1016/0005-2736(85)90521-8
Mayer, 1986, Biochim. Biophys. Acta, Biomembr., 858, 161, 10.1016/0005-2736(86)90302-0
Fettiplace, 1980, Physiol Rev, 60, 510, 10.1152/physrev.1980.60.2.510
Boman, 1993, Biochim. Biophys. Acta, Biomembr., 1152, 253, 10.1016/0005-2736(93)90256-Y
L. D. Mayer , T. D.Madden, M. B.Bally and P. RCullis, pH gradient-mediated drug entrapment in liposomes, in Liposome technology: Entrapment of drugs and other materials, ed. G. Gregoriadis, CRC Press, Boca Raton, 1993, pp. 27–44
Madden, 1990, Chem. Phys. Lipids, 53, 37, 10.1016/0009-3084(90)90131-A
Bolotin, 1994, J. Liposome Res., 4, 455, 10.3109/08982109409037057
Zhigaltsev, 2002, Biochim. Biophys. Acta, Biomembr., 1565, 129, 10.1016/S0005-2736(02)00543-6
Hays, 2001, Cryobiology, 42, 88, 10.1006/cryo.2001.2307
Marsh, 2003, Biochim. Biophys. Acta, Biomembr., 1615, 33, 10.1016/S0005-2736(03)00197-4
Li, 1998, Biochim. Biophys. Acta, Biomembr., 1415, 23, 10.1016/S0005-2736(98)00175-8
Kenworthy, 1995, Biophys. J., 68, 1921, 10.1016/S0006-3495(95)80369-3
Yatvin, 1978, Science, 202, 1290, 10.1126/science.364652
Lindner, 2004, Clin. Cancer Res., 10, 2168, 10.1158/1078-0432.CCR-03-0035
Lindner, 2008, J. Controlled Release, 125, 112, 10.1016/j.jconrel.2007.10.009
Tagami, 2011, J. Controlled Release, 152, 303, 10.1016/j.jconrel.2011.02.009
Tagami, 2011, J. Controlled Release, 154, 290, 10.1016/j.jconrel.2011.05.020
J.-Y. Park , PalmChurchen, and DavidNeedham, Formulation of Mn Prophyrin in LTSL, in preparation: to be submitted to Journal of Liposome Research, 2012
Fudickar, 1999, J. Am. Chem. Soc., 121, 9539, 10.1021/ja991738n
Hallock, 2003, Biophys. J., 84, 3052, 10.1016/S0006-3495(03)70031-9
Bert, 1980, Biochem J, 191, 761, 10.1042/bj1910761
Peters, 1983, J Biol Chem, 258, 11427, 10.1016/S0021-9258(17)44241-4
Nicholson, 1993, Biophys. J., 65, 2277, 10.1016/S0006-3495(93)81324-9
Gregor, 2005, Proc. Natl. Acad. Sci. U. S. A., 102, 18403, 10.1073/pnas.0509483102
Renkin, 1954, J Gen Physiol., 38, 225
Speelmans, 1994, Biochemistry, 33, 13761, 10.1021/bi00250a029
Hristova, 1995, Liq. Cryst., 18, 423, 10.1080/02678299508036641
O. G. Mouritsen , K.Jorgensen, and T.Honger, Permeability of Lipid Bilayers Near the Phase Transition, in Permeability and Stability of Lipid Bilayers.CRC Press, Boca Raton, 1995, pp. 137–160
Mouritsen, 1987, Phys. Rev. Lett., 58, 389, 10.1103/PhysRevLett.58.389
Zhelev, 1998, Biophys. J., 75, 321, 10.1016/S0006-3495(98)77516-2
Haest, 1972, Biochim. Biophys. Acta, Biomembr., 288, 43, 10.1016/0005-2736(72)90221-0
Chong, 2011, Soft Matter, 7, 4768, 10.1039/c1sm05181d
Mulet, 2009, ACS Nano, 3, 2789, 10.1021/nn900671u
Li, 2010, J. Controlled Release, 143, 274, 10.1016/j.jconrel.2010.01.006
Ickenstein, 2003, Biochim. Biophys. Acta, Biomembr., 1614, 135, 10.1016/S0005-2736(03)00196-2
